Literature DB >> 31699323

Can infections trigger alpha-synucleinopathies?

Christopher T Tulisiak1, Gabriela Mercado1, Wouter Peelaerts2, Lena Brundin1, Patrik Brundin3.   

Abstract

As synucleinopathies, Parkinson's disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases that involve the spread of pathogenic alpha-synuclein (αSyn) throughout the brain. Recent studies have suggested a role for αSyn as an antimicrobial peptide in response to PD- and MSA-related infections of peripheral tissues, including those in the respiratory, gastrointestinal, and urogenital systems. In this chapter, we examine epidemiological and experimental evidence for a role of peripheral microbial infections in triggering alpha-synucleinopathies. We propose a model of how infectious triggers, in conjunction with inflammatory, environmental, and genetic facilitators, may result in transfer of pathogenic αSyn strains from the periphery to the brain, where they propagate and spread. Finally, we discuss future research challenges and programs necessary to clarify the role of infections as triggers of PD and MSA and, ultimately, to prevent the onset of these diseases by infectious triggers.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Antimicrobial peptides; Bacteria; Facilitators; Fungi; Infections; Multiple system atrophy; Parkinson's disease; Triggers; Viruses

Mesh:

Substances:

Year:  2019        PMID: 31699323      PMCID: PMC6857718          DOI: 10.1016/bs.pmbts.2019.06.002

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  114 in total

1.  Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases.

Authors:  S McCall; J M Henry; A H Reid; J K Taubenberger
Journal:  J Neuropathol Exp Neurol       Date:  2001-07       Impact factor: 3.685

2.  Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

Authors:  Ben Readhead; Jean-Vianney Haure-Mirande; Cory C Funk; Matthew A Richards; Paul Shannon; Vahram Haroutunian; Mary Sano; Winnie S Liang; Noam D Beckmann; Nathan D Price; Eric M Reiman; Eric E Schadt; Michelle E Ehrlich; Sam Gandy; Joel T Dudley
Journal:  Neuron       Date:  2018-06-21       Impact factor: 17.173

3.  Direct visualization of fungal infection in brains from patients with Alzheimer's disease.

Authors:  Diana Pisa; Ruth Alonso; Angeles Juarranz; Alberto Rábano; Luis Carrasco
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 4.  Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism.

Authors:  Clive Weller; Norman Oxlade; Sylvia M Dobbs; R John Dobbs; André Charlett; Ingvar T Bjarnason
Journal:  FEMS Immunol Med Microbiol       Date:  2005-05-01

5.  Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014.

Authors:  Marie Villumsen; Susana Aznar; Bente Pakkenberg; Tine Jess; Tomasz Brudek
Journal:  Gut       Date:  2018-05-21       Impact factor: 23.059

6.  Viral hepatitis and Parkinson disease: A national record-linkage study.

Authors:  Julia Pakpoor; Alastair Noyce; Raph Goldacre; Marianna Selkihova; Stephen Mullin; Anette Schrag; Andrew Lees; Michael Goldacre
Journal:  Neurology       Date:  2017-03-29       Impact factor: 9.910

7.  A rat model of Parkinson's disease induced by Japanese encephalitis virus.

Authors:  A Ogata; K Tashiro; S Nukuzuma; K Nagashima; W W Hall
Journal:  J Neurovirol       Date:  1997-04       Impact factor: 2.643

8.  Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.

Authors:  Sarah A Gagliano; Jennie G Pouget; John Hardy; Jo Knight; Michael R Barnes; Mina Ryten; Michael E Weale
Journal:  Ann Clin Transl Neurol       Date:  2016-11-04       Impact factor: 4.511

Review 9.  Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic.

Authors:  S Pablo Sardi; Jesse M Cedarbaum; Patrik Brundin
Journal:  Mov Disord       Date:  2018-04-27       Impact factor: 10.338

Review 10.  Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.

Authors:  Sara Gerhardt; M Hasan Mohajeri
Journal:  Nutrients       Date:  2018-06-01       Impact factor: 5.717

View more
  17 in total

Review 1.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

2.  Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Authors:  Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder
Journal:  Mov Disord       Date:  2020-04-16       Impact factor: 10.338

3.  Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Authors:  Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder
Journal:  Mov Disord Clin Pract       Date:  2020-04-16

Review 4.  Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.

Authors:  Stanislav A Groppa; Dumitru Ciolac; Carolina Duarte; Christopher Garcia; Daniela Gasnaș; Pavel Leahu; Daniela Efremova; Alexandru Gasnaș; Tatiana Bălănuță; Daniela Mîrzac; Alexandru Movila
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.

Authors:  Harini Sri Rethinavel; Sowbarnika Ravichandran; Risna Kanjirassery Radhakrishnan; Mahesh Kandasamy
Journal:  J Chem Neuroanat       Date:  2021-05-11       Impact factor: 3.052

Review 6.  Covid-19 Infection and Parkinsonism: Is There a Link?

Authors:  Rabia Bouali-Benazzouz; Abdelhamid Benazzouz
Journal:  Mov Disord       Date:  2021-06-08       Impact factor: 9.698

Review 7.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  The role of viruses in the pathogenesis of Parkinson's disease.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 9.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

10.  Propagation of Pathological α-Synuclein from the Urogenital Tract to the Brain Initiates MSA-like Syndrome.

Authors:  Xuebing Ding; Lebo Zhou; Xiaoyi Jiang; Han Liu; Jing Yao; Rui Zhang; Dongxiao Liang; Fengfei Wang; Mingming Ma; Beisha Tang; Erxi Wu; Junfang Teng; Xuejing Wang
Journal:  iScience       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.